Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000173112223000849 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.52M	$10.68M	$12.77M
YoY Change	6292.01%	1571.62%
Cash & Equivalents	$16.52M	$10.68M	$12.77M
Short-Term Investments
Other Short-Term Assets	$158.8K	$496.3K	$519.7K
YoY Change	377.34%	2396.73%
Inventory	$522.0K	$42.83K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$17.20M	$11.22M	$13.29M
YoY Change	5474.55%	1603.04%	602.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$998.0K	$1.022M	$765.4K
YoY Change	163.75%	281.65%	224.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.520K	$7.520K	$7.520K
YoY Change
Other Assets			$0.00
YoY Change
Total Long-Term Assets	$1.125M	$1.170M	$935.0K
YoY Change	79.78%	138.94%	174.14%
TOTAL ASSETS
Total Short-Term Assets	$17.20M	$11.22M	$13.29M
Total Long-Term Assets	$1.125M	$1.170M	$935.0K
Total Assets	$18.32M	$12.39M	$14.22M
YoY Change	1861.62%	978.93%	536.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$79.12K	$49.56K	$99.03K
YoY Change	1353.84%	34.0%	642.73%
Accrued Expenses	$111.5K	$77.17K	$92.77K
YoY Change	168.63%	222.88%	164.08%
Deferred Revenue	$5.800K	$5.800K	$5.300K
YoY Change
Short-Term Debt	$104.0K	$0.00	$169.9K
YoY Change	832.26%	-100.0%
Long-Term Debt Due	$17.02K	$16.83K
YoY Change
Total Short-Term Liabilities	$406.9K	$237.1K	$453.2K
YoY Change	599.94%	96.98%	-34.36%
LONG-TERM LIABILITIES
Long-Term Debt	$67.72K	$72.74K	$0.00
YoY Change
Other Long-Term Liabilities	$23.07K	$45.92K	$68.53K
YoY Change
Total Long-Term Liabilities	$90.79K	$118.7K	$68.53K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$406.9K	$237.1K	$453.2K
Total Long-Term Liabilities	$90.79K	$118.7K	$68.53K
Total Liabilities	$497.7K	$355.8K	$521.7K
YoY Change	756.12%	195.54%	-24.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.576M	-$6.093M	-$4.088M
YoY Change	366.49%		793.37%
Common Stock	$15.78K	$10.45K	$10.45K
YoY Change	125.49%		49.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.82M	$12.04M	$13.70M
YoY Change
Total Liabilities & Shareholders Equity	$18.32M	$12.39M	$14.22M
YoY Change	1861.62%	978.93%	536.95%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001901305
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	FRZA	Due From Related Party Current DueFromRelatedPartyCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2023Q1	FRZA	Due To Affiliates Current DueToAffiliatesCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022Q1	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax		usd
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax		usd
CY2022Q1	us-gaap	Revenues Revenues		usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset		usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023Q1	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts		usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2022	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41469
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	FORZA X1, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3159685
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
CY2023Q1	dei	City Area Code CityAreaCode	(772)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	429-2525
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	FRZA
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10450000	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10683000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	42829	usd
CY2023Q1	FRZA	Due From Related Party Current DueFromRelatedPartyCurrent	129371	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	366983	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	519735	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	11222183	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13286934	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	140658	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7517	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7517	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1021674	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	765406	usd
CY2023Q1	us-gaap	Assets Assets	12392032	usd
CY2022Q4	us-gaap	Assets Assets	14221926	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	49555	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	99028	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77169	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	16830	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	87789	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5800	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5300	usd
CY2022Q4	FRZA	Due To Affiliates Current DueToAffiliatesCurrent	169851	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	237143	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	453191	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	72739	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45916	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q1	us-gaap	Liabilities Liabilities	355798	usd
CY2022Q4	us-gaap	Liabilities Liabilities	521723	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10450000	shares
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	10450000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10450000	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	10450000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10450	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10450	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18118548	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17777385	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6092764	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4087632	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12392032	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14221926	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	49941	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	11078	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-49941	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-11078	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	354662	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	77865	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	862764	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	182286	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	702648	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	215670	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	124040	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	19078	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35696	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7737	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2079810	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	502636	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2129751	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-513714	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	291	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	601	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	23	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	124910	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	124619	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-578	usd
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-2005132	usd
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-514292	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2005132	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-514292	usd
CY2023Q1	FRZA	Basic And Diluted Loss Per Common Share BasicAndDilutedLossPerCommonShare	-0.19
CY2022Q1	FRZA	Basic And Diluted Loss Per Common Share BasicAndDilutedLossPerCommonShare	-0.07
CY2023Q1	FRZA	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	10450000	shares
CY2022Q1	FRZA	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	7000000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1542949	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-514292	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1028657	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	341163	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2005132	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2005132	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-514292	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35696	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7737	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	341163	usd
CY2023Q1	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	21411	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42829	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-152752	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-68602	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-49473	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23645	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	500	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-11229	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15598	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-21072	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1582582	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-425537	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	199599	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39870	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199559	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39870	usd
CY2022Q1	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	116394	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2836	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	600557	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	110283	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	18151	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-302058	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-698800	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2084199	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1164207	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1803285	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10683000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	639078	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	291	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	601	usd
CY2023Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	92405	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zeTyaqcSaxsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_865_zky5SbW1VU7c">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10683000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zGrqEXV2hPmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_861_z3vCzgOEzO22">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_905_ecustom--FdicInsuredLimit_iI_pp0p0_c20230331_z7HRfqyqoDgl" title="FDIC insured limit">250,000</span> are at risk. As of March 31, 2023 and December 31, 2022, the Company had $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230331_zcSY5o1F7z3k" title="FDIC excess amount">10,271,464</span> and $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zDNB6GP23CCf" title="FDIC excess amount">12,446,216</span>, respectively, in excess of FDIC insured limits.</p>
CY2023Q1	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	10271464	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	12446216	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1105881	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	813917	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	84207	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	48511	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1021674	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	765406	usd
CY2023Q1	us-gaap	Depreciation Depreciation	35696	usd
CY2022Q1	us-gaap	Depreciation Depreciation	7737	usd
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0.0033
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P2Y
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7517	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q1	FRZA	Operating Lease Rou Asset OperatingLeaseRouAsset	140658	usd
CY2022	FRZA	Operating Lease Rou Asset OperatingLeaseRouAsset	162069	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	87789	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45916	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	133705	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154777	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	68552	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	61937	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	130489	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y6M29D
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	22550	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	22550	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	16830	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	72739	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47910	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	56581	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	29259	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36186	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77169	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10683000	usd
CY2023Q1	FRZA	Working Capital WorkingCapital	10985040	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2022Q4	FRZA	Working Capital WorkingCapital	12833743	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2005132	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-514292	usd
CY2023Q1	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2200	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	2200	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2027-08-16
CY2023Q1	FRZA	Warrant Activity WarrantActivity	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	341163	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.11	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.15	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0362	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1441500	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.41
CY2022	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P10Y
CY2022	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	4009913
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P10Y
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	36944	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.33
CY2023Q1	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y8M26D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1404556	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y6M3D
CY2023Q1	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	240583	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.21
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y5M8D

Files In Submission

Name	View Source	Status
0001731122-23-000849-index-headers.html	Edgar Link	pending
0001731122-23-000849-index.html	Edgar Link	pending
0001731122-23-000849.txt	Edgar Link	pending
0001731122-23-000849-xbrl.zip	Edgar Link	pending
e4677_10q.htm	Edgar Link	pending
e4677_ex31-1.htm	Edgar Link	pending
e4677_ex31-2.htm	Edgar Link	pending
e4677_ex32-1.htm	Edgar Link	pending
e4677_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frza-20230331_cal.xml	Edgar Link	unprocessable
frza-20230331_def.xml	Edgar Link	unprocessable
frza-20230331_lab.xml	Edgar Link	unprocessable
frza-20230331_pre.xml	Edgar Link	unprocessable
e4677_10q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2023 Q2 Form 10-Q Financial Statement

#000173112223000849 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission